Antimicrobial resistance (AMR) has emerged as one of the most formidable challenges to public health security worldwide, threatening the effectiveness of essential medical treatments and the management of infectious diseases. The relentless spread of resistant pathogens compromises the effectiveness of life-saving treatments, leading to longer hospital stays, higher medical costs, and increased mortality. This article delves into the profound and multifaceted impact of AMR, illustrating how it undermines the ability to treat common infections, perform routine surgeries, and manage chronic conditions. The vicious cycle of AMR not only exacerbates the burden on healthcare systems but also threatens to reverse decades of medical progress, potentially plunging the world into a post-antibiotic era where minor infections could once again be fatal. The article further explores the integral role of healthcare systems and policy frameworks in addressing this burgeoning crisis. It discusses how the lack of coordinated global strategies and inconsistent policy implementation have allowed AMR to flourish, emphasizing the need for robust healthcare infrastructures that prioritize the prevention and control of resistance. Critical measures such as enhancing global surveillance systems, promoting antimicrobial stewardship, and fostering innovation in new drug development are identified as pivotal in the fight against AMR. Moreover, the article highlights the importance of policy-driven interventions, including the enforcement of regulations on antibiotic use, investment in public health education, and the integration of AMR action plans into national health policies. By examining successful case studies and identifying gaps in current approaches, the article provides a comprehensive analysis of how healthcare systems and policy can be leveraged to combat AMR effectively. The discussion culminates in a call for a unified global response, underscoring that combating AMR requires not only technological advancements but also sustained political commitment and international collaboration to secure a safer, healthier future for all.
Published in | World Journal of Public Health (Volume 9, Issue 3) |
DOI | 10.11648/j.wjph.20240903.17 |
Page(s) | 286-294 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Antimicrobial Resistance (AMR), Global Health Threats, Public Health Security, Multidrug-Resistant Organisms, Infection Control, Public Health Policy, Healthcare Systems, Antibiotic Stewardship
[1] | Antimicrobial Resistance Collaborators. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet; 399(10325): P629-655. |
[2] |
Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014 Dec; 5(6): 229-41.
https://doi.org/10.1177/2042098614554919 PMID: 25436105; PMCID: PMC4232501. |
[3] |
Velazquez-Meza ME, Galarde-López M, Carrillo-Quiróz B, Alpuche-Aranda CM. Antimicrobial resistance: One Health approach. Vet World. 2022 Mar; 15(3): 743-749.
https://doi.org/10.14202/vetworld.2022.743-749 Epub 2022 Mar 28. PMID: 35497962; PMCID: PMC9047147. |
[4] | World Health Organization (WHO). "Antimicrobial Resistance: Global Report on Surveillance." 2014. |
[5] | Centers for Disease Control and Prevention (CDC). "Antibiotic Resistance Threats in the United States." 2019. |
[6] | World Bank. "Drug-Resistant Infections: A Threat to Our Economic Future." 2017. |
[7] | Review on Antimicrobial Resistance. "Tackling Drug-Resistant Infections Globally: Final Report and Recommendations." 2016. |
[8] | World Health Organization (WHO). (2020). Infection prevention and control. Retrieved from WHO. |
[9] | Centers for Disease Control and Prevention (CDC). (2021). Antibiotic Stewardship. Retrieved from CDC. |
[10] | World Health Organization (WHO). (2018). Global Antimicrobial Resistance Surveillance System (GLASS) report. Retrieved from WHO. |
[11] | Tamma, P. D., & Cosgrove, S. E. (2011). Antimicrobial stewardship programs. Clinical Microbiology Reviews, 24(3), 510-548. |
[12] | Dyar, O. J., et al. (2017). Strategies and challenges of antimicrobial stewardship in resource-limited settings. Journal of Antimicrobial Chemotherapy, 72(11), 2911-2918. |
[13] |
Ogyu A, Chan O, Littmann J, Pang HH, Lining X, Liu P, Matsunaga N, Ohmagari N, Fukuda K, Wernli D. National action to combat AMR: a One-Health approach to assess policy priorities in action plans. BMJ Glob Health. 2020 Jul; 5(7): e002427.
https://doi.org/10.1136/bmjgh-2020-002427 PMID: 32665430; PMCID: PMC7359186. |
[14] | Laxminarayan, R., Duse, A., Wattal, C., et al. (2013). Antibiotic Resistance—the Need for Global Solutions. The Lancet Infectious Diseases, 13(12), 1057-1098. |
[15] |
Dutescu IA, Hillier SA. Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study. Infect Drug Resist. 2021 Feb 5; 14: 415-434.
https://doi.org/10.2147/IDR.S287792 PMID: 33574682; PMCID: PMC7872909. |
[16] | Renwick, M. J., Brogan, D. M., & Mossialos, E. (2016). A Systematic Review and Critical Assessment of Incentive Strategies for Discovery and Development of Novel Antibiotics. The Journal of Antibiotics, 69(2), 73-88. |
[17] |
Ajulo S, Awosile B. Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. PLoS One. 2024 Feb 5; 19(2): e0297921.
https://doi.org/10.1371/journal.pone.0297921 PMID: 38315668; PMCID: PMC10843100. |
[18] |
Hu XY, Logue M, Robinson N. Antimicrobial resistance is a global problem - a UK perspective. Eur J Integr Med. 2020 Jun; 36: 101136.
https://doi.org/10.1016/j.eujim.2020.101136 Epub 2020 May 12. PMID: 32399092; PMCID: PMC7217106. |
[19] |
Köck R, Becker K, Idelevich EA, Jurke A, Glasner C, Hendrix R, Friedrich AW. Prevention and Control of Multidrug-Resistant Bacteria in The Netherlands and Germany-The Impact of Healthcare Structures. Int J Environ Res Public Health. 2020 Mar 30; 17(7): 2337.
https://doi.org/10.3390/ijerph17072337 PMID: 32235650; PMCID: PMC7178045. |
[20] | Gilham, E. L., Pearce-Smith, N., Carter, V. et al. Assessment of global antimicrobial resistance campaigns conducted to improve public awareness and antimicrobial use behaviours: a rapid systematic review. BMC Public Health 24, 396 (2024). |
[21] |
Sumpradit N, Wongkongkathep S, Malathum K, Janejai N, Paveenkittiporn W, Yingyong T, Chuxnum T, Vijitleela A, Boonyarit P, Akaleephan C, Manosuthi W, Thienthong V, Srinha J, Wongsrichai S, Laoprasert T, Athipunyakom P, Kriengchaiyaprug N, Intarukdach K, Numsawad S, Somjetanakul N, Punnin S, Kiatying-Angsulee N. Thailand's national strategic plan on antimicrobial resistance: progress and challenges. Bull World Health Organ. 2021 Sep 1; 99(9): 661-673.
https://doi.org/10.2471/BLT.20.280644 Epub 2021 Jul 1. PMID: 34475603; PMCID: PMC8381094. WHO Country Report on AMR: Netherlands. |
[22] |
Sabbatucci M, Ashiru-Oredope D, Barbier L, Bohin E, Bou-Antoun S, Brown C, Clarici A, Fuentes C, Goto T, Maraglino F, Morin J, Rönnefahrt I, Sanwidi A, Triggs-Hodge C, Vitiello A, Zovi A, Gelormini M, Lo Fo Wong D. Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps. Pharmacol Res. 2024 Jun; 204: 107188.
https://doi.org/10.1016/j.phrs.2024.107188 Epub 2024 May 3. PMID: 38705262; PMCID: PMC11156590. |
[23] |
Tangcharoensathien V, Sattayawutthipong W, Kanjanapimai S, Kanpravidth W, Brown R, Sommanustweechai A. Antimicrobial resistance: from global agenda to national strategic plan, Thailand. Bull World Health Organ. 2017 Aug 1; 95(8): 599-603.
https://doi.org/10.2471/BLT.16.179648 Epub 2017 May 11. PMID: 28804172; PMCID: PMC5537745. |
[24] |
Sumpradit N, Wongkongkathep S, Poonpolsup S, Janejai N, Paveenkittiporn W, Boonyarit P, Jaroenpoj S, Kiatying-Angsulee N, Kalpravidh W, Sommanustweechai A, Tangcharoensathien V. New chapter in tackling antimicrobial resistance in Thailand. BMJ. 2017 Sep 5; 358: j3415.
https://doi.org/10.1136/bmj.j2423 PMID: 28874352; PMCID: PMC5582296. |
[25] |
Piddock LJ. Antibiotic action: helping deliver action plans and strategies. Lancet Infect Dis. 2013 Dec; 13(12): 1009-11.
https://doi.org/10.1016/S1473-3099(13)70299-8 Epub 2013 Nov 17. PMID: 24252482. |
[26] |
Walsh TR, Gales AC, Laxminarayan R, Dodd PC. Antimicrobial Resistance: Addressing a Global Threat to Humanity. PLoS Med. 2023 Jul 3; 20(7): e1004264.
https://doi.org/10.1371/journal.pmed.1004264 PMID: 37399216; PMCID: PMC10317217. |
[27] | O'Neill, J. (2016). Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. |
[28] | Hollis, A., & Ahmed, Z. (2013). Preserving antibiotics, rationally. New England Journal of Medicine, 369(26), 2474-2476. |
[29] | Mendelson, M., & Matsoso, M. P. (2015). The World Health Organization Global Action Plan for antimicrobial resistance. South African Medical Journal, 105(5), 325-325. |
[30] |
Chen S, Zhang J, Wu Y. National Action Plan in Antimicrobial Resistance Using Framework Analysis for China. China CDC Wkly. 2023 Jun 2; 5(22): 492-498.
https://doi.org/10.46234/ccdcw2023.093 PMID: 37408616; PMCID: PMC10318557. |
APA Style
Sultana, M., Perves, N., Uddin, N., Chowdhury, M. K., Amin, N. (2024). The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR. World Journal of Public Health, 9(3), 286-294. https://doi.org/10.11648/j.wjph.20240903.17
ACS Style
Sultana, M.; Perves, N.; Uddin, N.; Chowdhury, M. K.; Amin, N. The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR. World J. Public Health 2024, 9(3), 286-294. doi: 10.11648/j.wjph.20240903.17
AMA Style
Sultana M, Perves N, Uddin N, Chowdhury MK, Amin N. The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR. World J Public Health. 2024;9(3):286-294. doi: 10.11648/j.wjph.20240903.17
@article{10.11648/j.wjph.20240903.17, author = {Maleka Sultana and Noman Perves and Nasir Uddin and Mahbub-E-Elahi Khan Chowdhury and Nurul Amin}, title = {The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR }, journal = {World Journal of Public Health}, volume = {9}, number = {3}, pages = {286-294}, doi = {10.11648/j.wjph.20240903.17}, url = {https://doi.org/10.11648/j.wjph.20240903.17}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20240903.17}, abstract = {Antimicrobial resistance (AMR) has emerged as one of the most formidable challenges to public health security worldwide, threatening the effectiveness of essential medical treatments and the management of infectious diseases. The relentless spread of resistant pathogens compromises the effectiveness of life-saving treatments, leading to longer hospital stays, higher medical costs, and increased mortality. This article delves into the profound and multifaceted impact of AMR, illustrating how it undermines the ability to treat common infections, perform routine surgeries, and manage chronic conditions. The vicious cycle of AMR not only exacerbates the burden on healthcare systems but also threatens to reverse decades of medical progress, potentially plunging the world into a post-antibiotic era where minor infections could once again be fatal. The article further explores the integral role of healthcare systems and policy frameworks in addressing this burgeoning crisis. It discusses how the lack of coordinated global strategies and inconsistent policy implementation have allowed AMR to flourish, emphasizing the need for robust healthcare infrastructures that prioritize the prevention and control of resistance. Critical measures such as enhancing global surveillance systems, promoting antimicrobial stewardship, and fostering innovation in new drug development are identified as pivotal in the fight against AMR. Moreover, the article highlights the importance of policy-driven interventions, including the enforcement of regulations on antibiotic use, investment in public health education, and the integration of AMR action plans into national health policies. By examining successful case studies and identifying gaps in current approaches, the article provides a comprehensive analysis of how healthcare systems and policy can be leveraged to combat AMR effectively. The discussion culminates in a call for a unified global response, underscoring that combating AMR requires not only technological advancements but also sustained political commitment and international collaboration to secure a safer, healthier future for all. }, year = {2024} }
TY - JOUR T1 - The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR AU - Maleka Sultana AU - Noman Perves AU - Nasir Uddin AU - Mahbub-E-Elahi Khan Chowdhury AU - Nurul Amin Y1 - 2024/09/20 PY - 2024 N1 - https://doi.org/10.11648/j.wjph.20240903.17 DO - 10.11648/j.wjph.20240903.17 T2 - World Journal of Public Health JF - World Journal of Public Health JO - World Journal of Public Health SP - 286 EP - 294 PB - Science Publishing Group SN - 2637-6059 UR - https://doi.org/10.11648/j.wjph.20240903.17 AB - Antimicrobial resistance (AMR) has emerged as one of the most formidable challenges to public health security worldwide, threatening the effectiveness of essential medical treatments and the management of infectious diseases. The relentless spread of resistant pathogens compromises the effectiveness of life-saving treatments, leading to longer hospital stays, higher medical costs, and increased mortality. This article delves into the profound and multifaceted impact of AMR, illustrating how it undermines the ability to treat common infections, perform routine surgeries, and manage chronic conditions. The vicious cycle of AMR not only exacerbates the burden on healthcare systems but also threatens to reverse decades of medical progress, potentially plunging the world into a post-antibiotic era where minor infections could once again be fatal. The article further explores the integral role of healthcare systems and policy frameworks in addressing this burgeoning crisis. It discusses how the lack of coordinated global strategies and inconsistent policy implementation have allowed AMR to flourish, emphasizing the need for robust healthcare infrastructures that prioritize the prevention and control of resistance. Critical measures such as enhancing global surveillance systems, promoting antimicrobial stewardship, and fostering innovation in new drug development are identified as pivotal in the fight against AMR. Moreover, the article highlights the importance of policy-driven interventions, including the enforcement of regulations on antibiotic use, investment in public health education, and the integration of AMR action plans into national health policies. By examining successful case studies and identifying gaps in current approaches, the article provides a comprehensive analysis of how healthcare systems and policy can be leveraged to combat AMR effectively. The discussion culminates in a call for a unified global response, underscoring that combating AMR requires not only technological advancements but also sustained political commitment and international collaboration to secure a safer, healthier future for all. VL - 9 IS - 3 ER -